Deepa Jagadeesh, Michal Taszner, Geoffrey Chong, Silvana Novelli, Seok-Goo Cho, Jose Caetano Villasboas, Michele Merli, Ana Jiménez Ubieto, Benoit Tessoulin, Michelle Poon, David Tucker, Jan Andrzej Walewski, Shuhua Yi, Jingxian Cai, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth R. Ambati, Tae Min Kim. "Long-term follow-up of the phase 2 ELM-2 study: Odronextamab for patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7049